Precision AQ – Investor Relations and External Communications

GettyImages-1884220155-Man_and_People_Conference_Room-RET (1)

1x1 Meetings with Precision AQ Clients in San Francisco — Formerly Stern Investor Relations

January 13 – 16, 2025

Precision AQ will be scheduling and hosting meetings for many of our clients around the 2025 J.P. Morgan Healthcare Conference.

This year we will be coordinating schedules for approximately 50 of our top-tier client companies, listed below with brief descriptions. To request specific meetings, please select those companies and fill out the short contact information form with your availability. A member of our team will follow up shortly for scheduling.

Our Solutions

From private to public, preclinical to commercial, we help companies at all stages map out strategic plans to thoughtfully engage with the financial community; highlight their innovation, expertise and leadership in their respective areas; and reach their financing goals. We craft timely and resonant messaging and seek to educate and expand clients’ share of voice while building credibility among key audiences both at and between milestones.

Value Message Development and Amplification

Our deep industry knowledge and research on best practices assist each client in crafting key messages. We integrate vision, the value and impact of scientific innovation, differentiation from peers, and specific expertise into narratives that build credibility and value and, importantly, resonate with key external stakeholders: investors, media, and industry thought leaders. We leverage our creative and digital capabilities to amplify company messaging across all interactive channels.

Investor and Industry Events and Corporate Access

We plan and execute virtual and live events to attract key investors, analysts, and other stakeholders. From traditional analyst and investor R&D days to KOL roundtables and events at medical conferences, we facilitate partnerships within our global network of thought leaders and stakeholders. Our premier corporate access event each January in San Francisco is one of the largest in the industry!

Sell-Side Engagement, Investor Targeting, and Outreach

We identify and connect clients with potential partners in equity research and investment banking who can further expand access, industry intelligence, and support. In addition, we have extensive knowledge and resources to ensure clients identify the right healthcare and biotechnology investors. We help manage these relationships, and provide tactical support on outreach and scheduling.

Financing Strategy and Preparing for Life as a Public Company

We work with companies from the very earliest stages, supporting company branding and website development, Series A financing, and the public launch. We also support companies in their transition to the public markets—via an IPO, SPAC, or reverse merger—and beyond! In each instance, our team is ready to guide clients through all the mission-critical infrastructure-building events and financing decisions, supporting everything from crossover rounds and syndicate selection to bake-offs and roadshow support.

Newsflow Planning

We strategically plan how, when, and where to disclose clinical, corporate, and financial news to generate the most value.

PR

We drive impactful media coverage across earned and paid channels, partnering with trusted expert spokespeople to deliver relevant, education-based storylines that resonate with key target audiences.